Real-time enrollment status for this head and neck cancer clinical trial
Current Status
Recruiting
Checked: October 27, 2026 at 5:37 PM UTC
| NCT Number | NCT06295731 |
| Recruiting Status | Recruiting |
| Condition | Head and Neck Cancer |
| Phase | PHASE2 |
| Target Enrollment | 450 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Inhibrx Biosciences, Inc |
| Last Updated on CT.gov | October 27, 2026 (17 hours ago) |
As of October 27, 2026: Clinical trial NCT06295731 is currently recruiting participants. This phase2 study for head and neck cancer is actively seeking new participants at 26 locations across the United States. The study is sponsored by Inhibrx Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06295731 is actively recruiting participants as of October 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06295731 was last updated 17 hours ago (October 27, 2026). HelloStudys verifies this status automatically.